# Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury

> **NCT00326976** · PHASE2 · COMPLETED · sponsor: **Fibrex Medical Research & Development GmbH** · enrollment: 234 (actual)

## Conditions studied

- Myocardial Ischemia
- Coronary Disease
- Myocardial Infarction

## Interventions

- **DRUG:** FX06
- **PROCEDURE:** Percutaneous coronary intervention

## Key facts

- **NCT ID:** NCT00326976
- **Lead sponsor:** Fibrex Medical Research & Development GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2007-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00326976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00326976, "Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00326976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*